Good observation. With dosing completed in the UK Parkinson Trial, more updates would be expected. If SNT 5505 demonstrates strong Phase II results, early equity positioning by Big Pharma makes sense to secure exclusivity and reduce competition. Looking forward to more clarity from the company. Great opportunity to buy more currently!
- Forums
- ASX - By Stock
- SNT
- SNT - Broker DATA
SNT
syntara limited
Add to My Watchlist
1.82%
!
5.6¢

SNT - Broker DATA, page-21
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.6¢ |
Change
0.001(1.82%) |
Mkt cap ! $91.05M |
Open | High | Low | Value | Volume |
5.5¢ | 5.6¢ | 5.5¢ | $28.02K | 501.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 46257 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.7¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 46257 | 0.056 |
1 | 97616 | 0.055 |
4 | 271543 | 0.054 |
1 | 60000 | 0.053 |
1 | 450000 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.057 | 20000 | 1 |
0.058 | 780000 | 1 |
0.060 | 492678 | 3 |
0.061 | 395000 | 1 |
0.067 | 330100 | 2 |
Last trade - 14.49pm 25/07/2025 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online